Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Special report by epic research 3 may 2013


Published on

Published in: Business, Economy & Finance
  • Be the first to comment

  • Be the first to like this

Special report by epic research 3 may 2013

  2. 2. HIGHLIGHTSA Highlights Nifty traded higher and ended in green on THURSDAY. Nifty Future ended 69.15 points up at 5999.35 Buy LT above 1554 for targets 1564/1574 sl 1542 Buy AURO PHARMA above 200 for targets 202/204with sl 197. Past Performance: KotakMahindra hit both tgts. HCL tech hit both targets ApolloTyre hit both targets. Bajaj Auto future hits 1st tg 1805. Bharti airtel hit both targets FIANANCIAL technologies hit both targets. Union bank hit both target. ICICI BANK HIT BOTH TGTS. WIPRO HIT 1ST TGT. IDEA HIT BOTH TGT.
  3. 3.  BUY LT above 1554. LT has made PENNANT on 15 min charts. Currently trading at 1552.60. Investor’s are advised to buy above 1554, break out hasyet to come. Targets are 1564/1574 and SL at 1545 This is an intra day day call as the pattern is forming on15 min chartLT - PENNANTBUY ABOVE 1554 FOR TARGETS 1564/1574 SL 1545BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235
  4. 4.  Buy AURO PHARMA above 200. AURO PHARMA is making FLAG on 15 min chart. Currently trading at 199.45 Investors’ are advised to buy above 200 for targets202/204, Breakout has yet to come. Targets are 202/204 and SL is to be followed 197AUROBINDO PHARMA– FLAGBUY ABOVE 200 FOR TARGETS 202/204 SL 197
  5. 5. DisclaimerThe information and view in this report, our website & all the service we provideare believed to be reliable, but we do not accept any responsibility (or liability) forerrors of fact or opinion. Users have the right to choose the product/s that suitsthem the most.Sincere efforts have been made to present the right investment perspective. Theinformation contained herein is based on analysis and up on sources that weconsider reliable.This material is for personal information and based upon it & takes noresponsibilityThe information given herein should be treated as only factor, while makinginvestment decision. The report does not provide individually tailor-madeinvestment advice. Epic research recommends that investors independentlyevaluate particular investments and strategies, and encourages investors to seekthe advice of a financial adviser. Epic research shall not be responsible for anytransaction conducted based on the information given in this report, which is inviolation of rules and regulations of NSE and BSE.The share price projections shown are not necessarily indicative of future priceperformance. The information herein, together with all estimates and forecasts, canchange without notice. Analyst or any person related to epic research might beholding positions in the stocks recommended. It is understood that anyone who isbrowsing through the site has done so at his free will and does not read any viewsexpressed as a recommendation for which either the site or its owners oranyone can be held responsible for . Any surfing and reading of the information isthe acceptance of this disclaimer.All Rights Reserved. Investment in equity & bullion market has its own risks.We, however, do not vouch for the accuracy or the completeness thereof. we are notresponsible for any loss incurred whatsoever for any financial profits or losswhich may arise from the recommendations above epic research does not purportto be an invitation or an offer to buy or sell any financial instrument. Our Clients(Paid Or Unpaid), Any third party or anyone else have no rights to forward orshare our calls or SMS or Report or Any other information provided by us to/withanyone which is related directly or indirectly with them. If found so, then SeriousLegal Actions can be taken.